InforCapital
CompanyChinaUpdated Feb 25, 2026
TF Capital

TF Capital

TF Capital: Investor • focus on Venture Capital • active in China, United States • offices in China • AUM $1.0B.

Company Profile

TF Capital is a venture capital firm headquartered in Shanghai, China, specializing in early-stage investments in the life sciences sector. Founded in 2013, the firm targets category-defining companies in biotechnology, therapeutics, pharmaceuticals, and related fields, providing not only capital but also strategic support through its network of advisors, industrialists, and tech leaders, particularly in the Asia Pacific region.

The firm emphasizes full value-chain support, from proprietary sourcing and partnerships with listed companies and clinical experts to facilitating license-out deals generating over $2B in upfronts from 18 transactions across 11 companies. With a portfolio exceeding 100 companies, 20 IPOs, and 94 investments documented, TF Capital has backed notable exits like Zai Lab and Structure Therapeutics, focusing on preclinical, clinical-stage, and growth opportunities in pharma R&D and biomedical technology.

TF Capital manages three funds, including Shanghai Taiyi Venture Investment Fund LP, and maintains a global outlook while prioritizing China-based innovation. Its team combines deep domain expertise with active involvement in go-to-market strategies, capital partnerships, and market insights to accelerate portfolio scaling in dynamic regions.

News & Signals (0)

No linked news activity found for this company.

Investor Listings

Similar Companies

Ranked by shared taxonomies: sector, subsector, geography, asset class and investor lists.

No similar companies found with overlapping taxonomy tags.